Ono Pharmaceutical Co Ltd 2018 Sustainability Report
The report records ONO's participation in the United Nations Global Compact in November 2017 and links its pharmaceutical activities to SDGs 3, 9, and 17. It reports FY2017 environmental data covering energy, water, emissions, and waste, including Scope 3 categories. Selected environmental quantitative information received limited independent assurance from Deloitte Tohmatsu Sustainability Co., Ltd.
Company: Ono Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2018
Type: Sustainability Report
Pages: 68
Back to company
Ono Pharmaceutical Co Ltd
CSR Report
The report records ONO's participation in the United Nations Global Compact in November 2017 and links its pharmaceutical activities to SDGs 3, 9, and 17. It reports FY2017 environmental data covering energy, water, emissions, and waste, including Scope 3 categories. Selected environmental quantitative information received limited independent assurance from Deloitte Tohmatsu Sustainability Co., Ltd.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Apr 1, 2017 - Mar 31, 2018
Fiscal Year
2017
Published
Aug 1, 2018
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Employees